ArticlePharmaceutical research2018
Investigation of the Discriminatory Ability of Pharmacokinetic Metrics for the Bioequivalence Assessment of PEGylated Liposomal Doxorubicin.
Li-Feng HsuPubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it